Vyome gets USPTO notice of allowance for VT-1908 topical mycophenolate patent application
Bitget2026/10/05 12:10Vyome received a USPTO Notice of Allowance for a U.S. patent application covering VT-1908, a topical ophthalmic mycophenolate program. Claims cover formulations and methods of use for inflammatory diseases, supporting IP protection around the candidate’s development plans. VT-1908 is being developed initially for anterior uveitis, targeting demand for steroid-sparing therapies in ocular inflammation. Vyome estimates the broader ocular inflammation market at more than $20 billion by 2035. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005278681) on October 05, 2026, and is solely responsible for the information contained therein.
- Vyome received a USPTO Notice of Allowance for a U.S. patent application covering VT-1908, a topical ophthalmic mycophenolate program.
- Claims cover formulations and methods of use for inflammatory diseases, supporting IP protection around the candidate’s development plans.
- VT-1908 is being developed initially for anterior uveitis, targeting demand for steroid-sparing therapies in ocular inflammation.
- Vyome estimates the broader ocular inflammation market at more than $20 billion by 2035.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.
Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Europe Becomes a Safe Haven Amid AI Turbulence! Citi Turns Bullish on European Stocks, Downgrades US Stocks: Low AI Exposure Seen as Key Advantage
Citigroup strategists have downgraded the rating of U.S. stocks and upgraded the rating of European stocks, following the recent market turbulence caused by upheaval in the artificial intelligence industry.
Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned
According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.
Crypto prices
More
